These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 2410941)

  • 1. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
    Roy A; Ninan P; Mazonson A; Pickar D; Van Kammen D; Linnoila M; Paul SM
    Psychol Med; 1985 May; 15(2):335-40. PubMed ID: 2410941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine metabolites in CSF and suicidal behavior.
    Träskman L; Asberg M; Bertilsson L; Sjöstrand L
    Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
    Sedvall GC; Wode-Helgodt B
    Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
    Linnoila M; Ninan PT; Scheinin M; Waters RN; Chang WH; Bartko J; van Kammen DP
    Arch Gen Psychiatry; 1983 Dec; 40(12):1290-4. PubMed ID: 6197036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R; Roos BE; Kampman R; Hyyppä S; Ranta P; Myllylä V
    Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.
    Engström G; Alling C; Blennow K; Regnéll G; Träskman-Bendz L
    Eur Neuropsychopharmacol; 1999 Sep; 9(5):399-405. PubMed ID: 10523046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF; Waldmeier P; Beckmann H
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
    Bertilsson L; Asberg M; Lantto O; Scalia-Tomba GP; Träskman-Bendz L; Tybring G
    Psychiatry Res; 1982 Feb; 6(1):77-83. PubMed ID: 6173891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
    Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
    Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF metabolites in borderline personality disorder compared with normal controls.
    Gardner DL; Lucas PB; Cowdry RW
    Biol Psychiatry; 1990 Aug; 28(3):247-54. PubMed ID: 1696137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels.
    Placidi GP; Oquendo MA; Malone KM; Huang YY; Ellis SP; Mann JJ
    Biol Psychiatry; 2001 Nov; 50(10):783-91. PubMed ID: 11720697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D; Pullar IA; Mawdsley C; Kinloch N; Yates CM
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF monoamine metabolites in mania.
    Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.
    Sedvall G; Fyrö B; Gullberg B; Nybäck H; Wiesel FA; Wode-Helgodt B
    Br J Psychiatry; 1980 Apr; 136():366-74. PubMed ID: 6155965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T; Hara S; Kuriiwa F; Kano S
    Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.